Patient Login
Clinical Trials
Career Opportunities
Contact Us

Home > Clinical Trials > Cancer Clinical Trial > Brain and Nervous System > A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients with High Grade Glioma

Print
A A A

A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients with High Grade Glioma

Protocol Number: ALLIANCE-A221101

NCT Number: NCT01781468

Condition/Disease: Cancer - Brain and Nervous System

Principal Investigator: Jose Carrillo

Status: Open

Treatment: Supportive Care

Drugs: Armodafinil, Placebo

Phase: III

Age Group: Adult

Scope: Local

Learn More:
For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.